EFFICACY OF OZANIMOD AS AN INDUCTION THERAPY IN ADVANCED THERAPY–NAIVE ULCERATIVE COLITIS PATIENTS SUBOPTIMALLY CONTROLLED ON CONVENTIONAL TREATMENTS

Peter Irving  1     Millie Long  2     Britta Siegmund  3     Geert D’Haens  4     Irina Blumenstein  5     Anjali Jain  6     Hsiuanlin Wu  6     Mark Osterman  6     Douglas C. Wolf  7     David T. Rubin  8    
1 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
2 UNC Chapel Hill, Chapel Hill, United States
3 Charité – Universitätsmedizin Berlin, Berlin, Germany
4 Amsterdam University Medical Center, Amsterdam, Netherlands
5 Goethe University Hospital, Frankfurt, Germany
6 Bristol Myers Squibb, Princeton, United States
7 Center for Crohn’s Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, United States
8 University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing